查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1961060

全球干细胞库市场：市场规模、产业动态、机会分析及预测（2026-2035 年），依分析服务类型、用途、细胞类型及地区划分

Global Stem Cell Banking Market: By Analysis Service Type, Utilization, Cell Type, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 310 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球干细胞库市场正经历快速扩张，反映出人们对再生医学日益增长的兴趣和取得的进展。 2025 年，该市场规模约为 77.5 亿美元，预计未来十年将显着成长，到 2035 年将达到 279.5 亿美元。这一显着增长意味着 2026 年至 2035 年预测期内的复合年增长率 (CAGR) 为 15.32%，表明该领域需求强劲，投资旺盛。

推动这令人瞩目的成长轨迹的关键因素有很多。其中一个关键驱动因素是专注于再生医学的临床试验数量不断增加，这正在扩大干细胞的治疗潜力。 这些试验探讨了针对多种疾病（从遗传性疾病到慢性病）的创新疗法，凸显了干细胞在下一代疗法中的关键作用。再生医学的进步不仅激发​​了科学界的兴趣，也增强了患者和医疗保健提供者对干细胞疗法疗效的信心。

市场趋势

干细胞库市场正在整合，前五大公司占了全球超过 54% 的市场。这种集中度反映了主要参与者利用其规模、技术和地理覆盖范围来实现区域主导地位和国际扩张的战略驱动力。 CBR Systems（也称为 California Cryobank）以超过 110 万份新生儿干细胞样本引领市场。

Revvity 的子公司 ViaCord 凭藉其尖端处理技术脱颖而出，显着提高了细胞回收率。这项技术优势使该公司能够提供高品质的干细胞产品，从而满足客户对储存样本最佳效果的需求。 同时，LifeCell International以其创新的 "社区银行" 模式进军印度市场，引领了新的潮流。

在东南亚，Cordlife Group已在新加坡、香港和菲律宾等主要市场建立了强大的影响力。凭藉在地化的专业知识和客製化的服务，该公司在这个快速成长的市场中占了相当大的占有率。这些领导企业正透过内生式成长以及併购来加速发展。

核心成长驱动因子

干细胞库需求的激增并非孤立现象。相反，它是多种人口结构变化和重要流行病学趋势共同作用的结果，这些变化正在从根本上改变世界医疗保健的方式。推动这一增长的最重要因素之一是全球慢性病和遗传性疾病负担的恶化。随着人口老化和生活方式的改变，癌症和自体免疫疾病等疾病的盛行率越来越高，迫切需要新的疾病预防、管理和治疗策略。

新机会与趋势

2025年，干细胞库市场将迎来重大变革。其关注点将从简单的生物材料保存转向采用先进的生物资讯技术。这项演化标誌着干细胞冷冻保存模式正从传统的模式转向更全面、更先进的方法，整合尖端基因组技术。目前，各大干细胞库正透过将保存服务与完整的基因组分析相结合来扩展其服务范围，从而实现对新生儿DNA的详细分析。这个过程有助于在生命早期识别和绘製潜在的健康风险图谱，提供超越干细胞保存本身的宝贵见解。

优化障碍

由于严格、分散且频繁变化的国际法规，干细胞库市场面临巨大的挑战。这种监管复杂性在美国和欧盟等主要市场尤为突出，因为每个主管机构都制定了严格的标准，以确保干细胞材料的安全性、品质和伦理处理。 应对这些繁杂且严格的监管规定给干细胞库运营商带来了沉重的负担，需要投入大量成本，包括法律专业知识、营运协调和持续监管等方面的投入。这种监管负担会扼杀创新，使跨国营运复杂化，导致企业难以简化流程并有效扩大全球业务规模。

目录

第一章：研究架构

  • 研究目标
  • 产品概述
  • 市场区隔

第二章：研究方法

  • 质性研究
    • 一手和二手资料来源
  • 量化研究
    • 一手和二手资料来源
  • 依国家/地区划分的一手调查受访者组成
  • 研究假设
  • 市场规模估算
  • 资料三角验证

第三章：摘要整理：全球

第四章：全球干细胞库市场概论

  • 产业价值链分析
    • 服务提供者
    • 最终用户
  • 行业展望
    • 主要国家癌症统计（2025 年）
    • 各国当前人均医疗支出（美元）
  • PESTLE 分析
  • 波特五力分析
    • 供应商议价能力
    • 买方议价能力
    • 替代品威胁
    • 新进入者威胁
    • 竞争强度
  • 市场动态与趋势
    • 成长驱动因素
    • 限制因素
    • 挑战
    • 主要趋势
  • 市场成长与展望
    • 市场收入估算与预测（2020-2035 年）
    • 价格趋势分析
  • 竞争格局概览
    • 市场集中度
    • 公司占有率分析（基于价值，2025 年）
    • 竞争格局分析与基准分析

第五章：全球干细胞库市场依服务类型分析

  • 主要发现
  • 市场规模与预测（2020-2035 年）
    • 采集与运输
    • 处理
    • 分析
    • 存储

第六章：全球干细胞库市场依用途分析

  • 关键研究结果
  • 市场规模及预测，2020-2035 年
    • 已使用
    • 未使用

第七章 全球干细胞库市场分析：依干细胞类型划分

  • 主要见解
  • 市场规模及预测，2020-2035 年
    • 脐带血干细胞
    • 成体干细胞
    • 胚胎干细胞

第八章 全球干细胞库市场分析：依地区划分

  • 主要见解
  • 市场规模及预测，2020-2035 年
    • 北美
    • 欧洲
    • 亚太地区
    • 中东和非洲
    • 南美洲

第九章：北美干细胞库市场分析

第十章：欧洲干细胞库市场分析

第十一章：亚太地区干细胞库市场分析

第十二章：中东与非洲干细胞库市场分析

第十三章：南美洲干细胞库市场分析

第14章 企业简介

  • Biocell
  • CBR Systems, Inc.
  • Cordlife
  • Cryo-Cell International, Inc.
  • CryoSave South Africa(Pty)Ltd.
  • Cryoviva
  • Future Health Biobank
  • LifeCell International Pvt. Ltd.
  • Smart Cells International Ltd
  • ViaCord
  • Other Prominent Players
简介目录
Product Code: AA01261656

The global stem cell banking market is undergoing rapid expansion, reflecting growing interest and advancements in regenerative medicine. Valued at approximately USD 7.75 billion in 2025, the market is projected to experience substantial growth over the next decade, with forecasts estimating it will reach a valuation of USD 27.95 billion by 2035. This remarkable increase corresponds to a compound annual growth rate (CAGR) of 15.32% during the forecast period from 2026 to 2035, signaling robust demand and investment across the sector.

Several key factors are driving this impressive growth trajectory. One of the primary catalysts is the rising number of clinical trials focused on regenerative medicine, which is expanding the therapeutic potential of stem cells. These trials are exploring innovative treatments for a wide range of diseases, from genetic disorders to chronic conditions, highlighting the critical role stem cells play in next-generation therapies. The progress in regenerative medicine not only fuels scientific interest but also increases patient and healthcare provider confidence in the efficacy of stem cell-based treatments.

Noteworthy Market Developments

The stem cell banking market is increasingly defined by consolidation, with the top five players capturing over 54% of the global market share. This concentration reflects a strategic push by leading companies to leverage scale, technology, and geographic reach to dominate their respective regions and expand internationally. CBR Systems, also known as California Cryobank, leads the market in volume, boasting an inventory of more than 1.1 million newborn stem cell samples.

ViaCord, now part of Revvity, distinguishes itself through cutting-edge processing technologies that significantly enhance cell recovery rates. This technological edge allows ViaCord to offer superior quality stem cell products, which appeals to clients seeking the best possible outcomes from their stored samples. Meanwhile, LifeCell International has disrupted the Indian market with an innovative "community banking" model.

In Southeast Asia, Cordlife Group has established a stronghold, thriving in key markets such as Singapore, Hong Kong, and the Philippines. Their regional expertise and tailored service offerings have helped them capture a significant share of this growing market. These leading companies are not only expanding organically but are also accelerating growth through mergers and acquisitions.

Core Growth Drivers

The surge in demand for the stem cell banking market is not a phenomenon occurring in isolation; rather, it is the result of several converging demographic shifts and significant epidemiological trends that are fundamentally transforming the approach to healthcare worldwide. One of the most influential drivers behind this growing interest is the increasing global burden of chronic and genetic diseases. As populations age and lifestyles change, conditions such as cancer and autoimmune disorders are becoming more prevalent, creating an urgent need for new strategies in disease prevention, management, and treatment.

Emerging Opportunity Trends

In 2025, the stem cell banking market undergoes a significant transformation as the focus shifts from simply storing biological materials to embracing advanced bioinformatics. This evolution marks a departure from the traditional model of freezing and preserving stem cells toward a more comprehensive and sophisticated approach that integrates cutting-edge genomic technologies. Leading stem cell banks are now expanding their service offerings by combining storage with full genomic profiling, allowing them to sequence the newborn's DNA in detail. This process enables the identification and mapping of potential health risks early in life, providing valuable insights that go far beyond the preservation of stem cells alone.

Barriers to Optimization

The stem cell banking market faces significant challenges due to stringent, fragmented, and frequently evolving international regulations. These regulatory complexities are especially pronounced in major markets such as the United States and the European Union, where governing bodies impose rigorous standards to ensure the safety, quality, and ethical handling of stem cell materials. Compliance with these diverse and often stringent regulations demands substantial investments in legal expertise, operational adjustments, and ongoing monitoring, all of which contribute to increased costs for stem cell banking providers. This regulatory burden can slow down innovation and complicate cross-border operations, making it more difficult for companies to streamline processes and scale efficiently on a global level.

Detailed Market Segmentation

By Utilization, the unused segment, which consists of stem cell units that have been cryopreserved but not yet released or utilized, dominates the volume of the stem cell banking market. This prevalence is largely a reflection of the significant gap between the rates at which stem cells are preserved and the rates at which they are actually used. While many individuals and families choose to bank stem cells as a precautionary measure or biological safeguard, the actual clinical application of these stored units remains relatively low in comparison. This economic reality shapes the market's volume dynamics, with a large inventory of preserved cells remaining in storage without immediate demand for release or treatment.

By Service Type, the storage segment holds the largest value share in the stem cell banking market because it serves as the industry's primary source of recurring revenue. Unlike one-time services such as collection or processing, storage involves ongoing fees that clients pay regularly to maintain the preservation of their stem cell samples over extended periods. This continuous revenue stream provides financial stability and growth potential for stem cell banks, making storage a critical component of their business models.

By Bank, the private bank segment overwhelmingly dominates the global stem cell banking market, commanding approximately 97% of the industry's financial value. This significant market share highlights the strong preference among consumers and healthcare providers for private banking services over other types of stem cell storage options. Private banks offer exclusive storage of an individual's stem cells, typically for personal or family use, which appeals to many who view this as a form of biological insurance for potential future medical treatments. This personalized approach not only drives higher revenue per client but also fosters a deep sense of security and control, factors that contribute to the segment's financial dominance.

By Cell Type, the umbilical cord stem cell segment holds the largest share within the stem cell banking market, a position it has secured due to several compelling advantages. One of the primary reasons for its dominance is the superior biological plasticity of umbilical cord stem cells. These cells possess a remarkable ability to differentiate into a wide range of cell types, making them highly valuable for various regenerative medicine applications and potential therapeutic interventions. Their versatility enhances their appeal to both medical professionals and prospective clients, as they offer promising prospects for treating a broad spectrum of diseases and conditions.

Segment Breakdown

By Service Type

  • Collection & Transportation
  • Processing
  • Analysis
  • Storage

By Utilization

  • Used
  • Unused

By Cell Type

  • Umbilical Cord Stem Cell
  • Adult Stem Cell
  • Embryonic Stem Cell

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • South America

Geography Breakdown

  • North America continues to dominate the industry, accounting for approximately 38% to 40% of the market revenue in 2026. This stronghold is underpinned by a combination of deep-rooted structural advantages that set the region apart from others. At the core of this dominance is North America's status as the home to the world's most advanced regenerative medicine infrastructure.
  • In addition to the sophisticated medical infrastructure, North America benefits from high disposable incomes that enable many families to invest in premium health services, including stem cell banking. The cultural acceptance and enthusiasm for "paying for health edges" further fuel this adoption, as consumers are increasingly willing to pay upfront for services that they perceive as long-term investments in their children's health and future well-being.

Leading Market Participants

  • Biocell
  • CBR Systems, Inc.
  • Cordlife
  • Cryo-Cell International, Inc.
  • CryoSave South Africa (Pty) Ltd.
  • Cryoviva
  • Future Health Biobank
  • LifeCell International Pvt. Ltd.
  • Smart Cells International Ltd
  • ViaCord
  • Other Prominent Players

Table of Content

Chapter 1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

Chapter 2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Country
  • 2.4. Assumption for the Study
  • 2.5. Market Size Estimation
  • 2.6. Data Triangulation

Chapter 3. Executive Summary: Global

Chapter 4. Global Stem Cell Banking Market Overview

  • 4.1. Industry Value Chain Analysis
    • 4.1.1. Service Provider
    • 4.1.2. End User
  • 4.2. Industry Outlook
    • 4.2.1. Cancer Statistics in Major Countries, 2025
    • 4.2.2. Current health expenditure per capita (current US$) - By Country
  • 4.3. PESTLE Analysis
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Suppliers
    • 4.4.2. Bargaining Power of Buyers
    • 4.4.3. Threat of Substitutes
    • 4.4.4. Threat of New Entrants
    • 4.4.5. Degree of Competition
  • 4.5. Market Dynamics and Trends
    • 4.5.1. Growth Drivers
    • 4.5.2. Restraints
    • 4.5.3. Challenges
    • 4.5.4. Key Trends
  • 4.6. Market Growth and Outlook
    • 4.6.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
    • 4.6.2. Price Trend Analysis
  • 4.7. Competition Dashboard
    • 4.7.1. Market Concentration Rate
    • 4.7.2. Company Market Share Analysis (Value %), 2025
    • 4.7.3. Competitor Mapping & Benchmarking

Chapter 5. Global Stem Cell Banking Market Analysis, By Service Type

  • 5.1. Key Insights
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. Collection & Transportation
    • 5.2.2. Processing
    • 5.2.3. Analysis
    • 5.2.4. Storage

Chapter 6. Global Stem Cell Banking Market Analysis, By Utilization

  • 6.1. Key Insights
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. Used
    • 6.2.2. Unused

Chapter 7. Global Stem Cell Banking Market Analysis, By Stem Cell Type

  • 7.1. Key Insights
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. Umbilical Cord Stem Cell
    • 7.2.2. Adult Stem Cell
    • 7.2.3. Embryonic Stem Cell

Chapter 8. Global Stem Cell Banking Market Analysis, By Region

  • 8.1. Key Insights
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. North America
      • 8.2.1.1. The U.S.
      • 8.2.1.2. Canada
      • 8.2.1.3. Mexico
    • 8.2.2. Europe
      • 8.2.2.1. Western Europe
        • 8.2.2.1.1. The UK
        • 8.2.2.1.2. Germany
        • 8.2.2.1.3. France
        • 8.2.2.1.4. Italy
        • 8.2.2.1.5. Spain
        • 8.2.2.1.6. Rest of Western Europe
      • 8.2.2.2. Eastern Europe
        • 8.2.2.2.1. Poland
        • 8.2.2.2.2. Russia
        • 8.2.2.2.3. Rest of Eastern Europe
    • 8.2.3. Asia Pacific
      • 8.2.3.1. China
      • 8.2.3.2. India
      • 8.2.3.3. Japan
      • 8.2.3.4. South Korea
      • 8.2.3.5. Australia & New Zealand
      • 8.2.3.6. ASEAN
          • 8.2.3.6.1.1. Indonesia
          • 8.2.3.6.1.2. Malaysia
          • 8.2.3.6.1.3. Thailand
          • 8.2.3.6.1.4. Singapore
          • 8.2.3.6.1.5. Rest of ASEAN
      • 8.2.3.7. Rest of Asia Pacific
    • 8.2.4. Middle East & Africa
      • 8.2.4.1. UAE
      • 8.2.4.2. Saudi Arabia
      • 8.2.4.3. South Africa
      • 8.2.4.4. Rest of MEA
    • 8.2.5. South America
      • 8.2.5.1. Argentina
      • 8.2.5.2. Brazil
      • 8.2.5.3. Rest of South America

Chapter 9. North America Stem Cell Banking Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. By Service Type
    • 9.2.2. By Utilization
    • 9.2.3. By Stem Cell Type
    • 9.2.4. By Country

Chapter 10. Europe Stem Cell Banking Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. By Service Type
    • 10.2.2. By Utilization
    • 10.2.3. By Stem Cell Type
    • 10.2.4. By Country

Chapter 11. Asia Pacific Stem Cell Banking Market Analysis

  • 11.1. Market Dynamics and Trends
    • 11.1.1. Growth Drivers
    • 11.1.2. Restraints
    • 11.1.3. Opportunity
    • 11.1.4. Key Trends
  • 11.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 11.2.1. By Service Type
    • 11.2.2. By Installation Type
    • 11.2.3. By Stem Cell Type
    • 11.2.4. By Country

Chapter 12. Middle East & Africa Stem Cell Banking Market Analysis

  • 12.1. Market Dynamics and Trends
    • 12.1.1. Growth Drivers
    • 12.1.2. Restraints
    • 12.1.3. Opportunity
    • 12.1.4. Key Trends
  • 12.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 12.2.1. By Service Type
    • 12.2.2. By Installation Type
    • 12.2.3. By Utilization
    • 12.2.4. By Stem Cell Type
    • 12.2.5. By Country

Chapter 13. South America Stem Cell Banking Market Analysis

  • 13.1. Market Dynamics and Trends
    • 13.1.1. Growth Drivers
    • 13.1.2. Restraints
    • 13.1.3. Opportunity
    • 13.1.4. Key Trends
  • 13.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 13.2.1. By Service Type
    • 13.2.2. By Utilization
    • 13.2.3. By Stem Cell Type
    • 13.2.4. By Country

Chapter 14. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 14.1. Biocell
  • 14.2. CBR Systems, Inc.
  • 14.3. Cordlife
  • 14.4. Cryo-Cell International, Inc.
  • 14.5. CryoSave South Africa (Pty) Ltd.
  • 14.6. Cryoviva
  • 14.7. Future Health Biobank
  • 14.8. LifeCell International Pvt. Ltd.
  • 14.9. Smart Cells International Ltd
  • 14.10. ViaCord
  • 14.11. Other Prominent Players